Figure 4 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
<p><b>A,</b> Fold changes in key metabolites identified by multivariate analysis concentrations in unwell patients with solid tumors relative to the mean metabolite concentrations in unwell patients without cancer. <b>B,</b> Fold changes in key metabolite concentrations...
Shranjeno v:
| Glavni avtor: | |
|---|---|
| Drugi avtorji: | , , , , , , , , , , , , |
| Izdano: |
2025
|
| Teme: | |
| Oznake: |
Označite
Brez oznak, prvi označite!
|
| Izvleček: | <p><b>A,</b> Fold changes in key metabolites identified by multivariate analysis concentrations in unwell patients with solid tumors relative to the mean metabolite concentrations in unwell patients without cancer. <b>B,</b> Fold changes in key metabolite concentrations in patients with metastatic cancer, relative to the mean metabolite concentration in patients with nonmetastatic cancer. <b>C,</b> Venn diagram illustrating direction of metabolite concentration changes in metastatic and nonmetastatic cancers, relative to unwell patients without cancer. HDL, high-density lipoprotein. Note that “/” represents that the two metabolites overlap in the NMR data, and not a ratio of the two metabolite concentrations. Individual plots of metabolite concentrations are given in Supplementary Fig. S4.</p> |
|---|